ArticleScientific reports2025
Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated assessment of right heart function by artificial intelligence: A systematic review and meta-analysis.European journal of radiology open · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
Abstract
Right ventricular dysfunction (RVD) is strongly associated with increased mortality in patients with acute pulmonary embolism (PE), making its early detection crucial. Identifying RVD risk factors rapidly, accurately, and economically within the acute PE population could significantly improve diagnosis and treatment, potentially reducing mortality rates. This study evaluates the performance of LogNNet and supervised machine learning (ML) models for diagnosing RVD using a repeated stratified hold-out validation procedure. An ensemble-based LogNNet model is proposed for practical application. The LogNNet model identified gender, coronary artery disease, Comorbid Disease (especially hypertension), age (above 74-years), Thrombus segment and un/bilateral Thrombus as the most significant predictors for RVD diagnosis. Additionally, combinations of these features demonstrated high predictive power. LogNNet achieved robust results with only a few selected features, making it suitable for applications in resource-limited environments. LogNNet provides a practical and accessible tool for early RVD detection using PE patient data and has been shown to support applications in healthcare innovations aimed at improving patient outcomes and resilience in edge devices, clinical decision support systems, and challenging environments. Furthermore, these findings could be used as promising applications by integrating with advances in digital health and human health monitoring systems, such as bionic clothing and smart sensor networks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.